Neurosciences Books

Book SynopsisA Next Big Idea Club Must-ReadA compelling and accessible new perspective on the modern science of psychology, based on one of Yale’s most popular courses of all timeHow does the brain—a three-pound wrinkly mass—give rise to intelligence and conscious experience? Was Freud right that we are all plagued by forbidden sexual desires? What is the function of emotions such as disgust, gratitude, and shame? Renowned psychologist Paul Bloom answers these questions and many more in Psych, his riveting new book about the science of the mind.Psych is an expert and passionate guide to the most intimate aspects of our nature, serving up the equivalent of a serious university course while being funny, engaging, and full of memorable anecdotes. But Psych is much more than a comprehensive overview of the field of psychology. Bloom reveals what psychology can tell us about the most pressing moral and political issues of our time—including belief in conspiracy theories, the role of genes in explaining human differences, and the nature of prejudice and hatred.Bloom also shows how psychology can give us practical insights into important issues—from the treatment of mental illnesses such as depression and anxiety to the best way to lead happy and fulfilling lives. Psych is an engrossing guide to the most important topic there is: it is the story of us.

Read more less

Book SynopsisIncorporates findings on developmental gene expression and shows the boundaries of neuromeres in the diencephalon and brain stem. This book features: 161 thoroughly revised coronal diagrams and accompanying photographic plates spaced at 120 m intervals; and 19 thoroughly revised sagittal diagrams and accompanying photographic plates.Trade Review"…this version contains 161 revised coronal diagrams with accompanying photographic plates of microtome slides taken at 120 micrometer intervals through the brain from its anterior to posterior end…The book will be useful to students and teachers of neuroanatomy in medical schools, with additional uses in neurological research and specialist veterinary medicine." --ProtoView.com, March 2014Table of ContentsFeatures of the Edition Introduction Methods Stereotaxic reference system Nomenclature and the construction of abbreviations The basis of delineation of structures References Index of structures Index of abbreviations Parts of the rat brain Figures

Read more less

Book SynopsisTable of ContentsNEURONS, SYNAPSES, AND CIRCUITS 1. Membrane Voltage 2. Dynamics of the Action Potential 3. Synaptic Transmission 4. Synaptic Plasticity 5. Neuromodulators 6. Neuronal Communication Beyond Synapses 7. Microcircuits of the Neocortex 8. Microcircuits of the Hippocampus MEASURING, PERTURBING, AND ANALYZING BRAIN NETWORKS 9. Unit Activity 10. LFP and EEG 11. Optical Measurements and Perturbations 12. Imaging Structural Networks With MRI 13. Imaging Functional Networks With MRI 14. Deep Brain Stimulation 15. Noninvasive Brain Stimulation 16. Network Interactions CORTICAL OSCILLATIONS 17. Low-Frequency Oscillations 18. Theta Oscillations 19. Alpha Oscillations 20. Beta Oscillations 21. Gamma Oscillations 22. High-Frequency Oscillations NETWORK DISORDERS 23. Parkinson’s Disease 24. Epilepsy 25. Schizophrenia 26. Autism Spectrum Disorders 27. Major Depressive Disorder TOOLBOXES Toolbox Neurons, Toolbox Animal Models, Toolbox Neurology, Toolbox Psychiatry, Toolbox Matlab, Toolbox Electrical Circuits, Toolbox Differential Equations, Toolbox Dynamical Systems, Toolbox Graph Theory, Toolbox Modeling Neurons, Toolbox Physics of Electric Fields, Toolbox Time and Frequency

Read more less

Book Synopsis

Read more less

Book SynopsisTable of Contents1. Neural Induction 2. Polarity and Segmentation 3. Genesis and Migration 4. Generation of Neural Diversity 5. Wiring up the Brain: Axon Navigation 6. Differentiation 7. Naturally-Occurring Neuron Death 8. Synapse Formation 9. Refinement of Synaptic Connections 10. Behavioral Development

Read more less

Book Synopsis

Read more less

Book SynopsisTable of Contents1. Organization of the spinal cord 2. Development of the spinal cord 3. Vertebral column and spinal meninges 4. Spinal nerves 5. Primary afferent projections to the spinal cord 6. Cytoarchitecture of the spinal cord 7. Motor neurons of the spinal cord 8. The preganglionic motor column 9. Projections from the spinal cord to the brain 10. Projections from the brain to the spinal cord 11. Pattern generation in the spinal cord 12. Spinal cord transmitter substances 13. Gene expression in the neonate and adult mouse spinal cord 14. Spinal cord imaging 15. The lamprey spinal cord – Primordial vertebrate organization 16. Atlas of the rat spinal cord 17. Atlas of the mouse spinal cord 18. Atlas of the newborn mouse spinal cord 19. Atlas of the marmoset spinal cord 20. Atlas of the rhesus monkey spinal cord 21. Atlas of the human spinal cord

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisTable of ContentsSection 1 Dementia: Introductory Chapters 1. A review of the different types of dementia2. The classification of dementia: problems and challenges3. Alzheimer’s disease: an overview4. Dementia and competing hypothesis – the example of Alzheimer’s disease and its various hypotheses5. Lewy body dementia – an overview6. Mixed dementia – an overview7. Vascular dementia – an overview8. Linking in physical activity and dementia9. Risk factors in dementia10. Mortality in dementia – linking in delirium11. Rare forms of dementia12. Prion diseases and dementia13. Dementia in Parkinson disease14. Dementia in traumatic brain injury15. Risk factors in dementia – towards a coherent theory of dementia16. Genetics of dementia Section 2 Biomarkers, Psychometric Instruments, and Diagnosis 17. Circulating biomarkers in neurodegenerative dementias – YKL-40 and beyond18. Salivary biomarkers in Alzheimer’s disease19. Use of cerebrospinal fluid in diagnosis of dementias20. SPECT perfusion imaging in assessment of neurodegenerative dementias21. Computerised tomography (CT) in assessment of neurodegenerative dementias22. Magnetic resonance imaging (MRI) in assessment of neurodegenerative dementias23. Questionnaires: The mini-mental state examination (MMSE) and beyond24. The Cambridge Mental Disorders of the Elderly Examination (CAMDEX) and applications to dementia25. The Montreal Cognitive Assessment (MoCA) and applications to dementia26. The Hopkins Verbal Learning Test (HVLT) and applications to dementia27. The Addenbrooke’s Cognitive Examination (ACE) and applications to dementia28. ALBA Screening Instrument (ASI) and applications to dementia29. The prediction of Alzheimer’s disease Section 3 Pharmacological Treatments for Dementia30. Cholinesterase inhibitors in dementias – an overview31. NMDA receptor antagonists in dementia – an overview32. Donepezil usage – a focused review33. Rivastigmine usage – a focused review34. Galantamine usage – a focused review35. Memantine – a focused review36. Failures and successes of monoclonal antibodies – bapineuzumab and beyond37. Immunotherapies: an overview Section 4 Non-Pharmacological Treatments38. Internet counselling39. Counselling in dementia40. Cognitive rehabilitation in dementia41. Cognitive stimulation in dementia42. Anodal Transcranial Direct Current Stimulation43. Nanoparticles: nanodiamond treatment in Alzheimer’s disease44. Increasing intakes and improving nutritional status in dementia45. All-trans retinoic acid in Alzheimer’s disease46. Environmental enrichment in dementia47. Music therapy in dementia48. Aromatherapy in dementia49. Massage in dementia50. Dancing in dementia51. Multisensory Stimulation in Dementia52. Animal-assisted therapy in dementia53. Occupational therapy in dementia

Read more less

Book SynopsisTable of ContentsPart I: Genetics, molecular and cellular biology 1. The neuron navigator 2 gene and Alzheimer’s diseaseChun Xu, Brenda Bin Su, Stephanie Lozano and Kesheng Wang 2. Interlinking polymorphisms, estrogens, and Alzheimer diseaseLu Hua Chen, Leung Wing Chu and You-Qiang Song 3. Linking EEGs, Alzheimer disease, and the phosphatidylinositol-binding clathrin assembly protein (PICALM) geneNatalya Ponomareva, Tatiana Andreeva, Vitaly Fokin, Sergey Illarioshkin and Evgeny Rogaev 4. CD36 gene polymorphisms and Alzheimer’s diseaseOmar Šerý, Nandu Goswami and Vladimir J. Balcar 5. Genetic contributions to sporadic frontotemporal dementiaJessie S. Carr, Daniel W. Sirkis and Jennifer S. Yokoyama 6. Clinical response to cholinesterase inhibitors in dementia: the role of CYP2D6 and APOE genetic polymorphismsLuís Felipe José Ravic de Miranda, Karina Braga Gomes and Paulo Caramelli 7. A1 and A2 purinergic receptor expression in dementiaJ. Mendiola-Precoma, L.C. Berumen, A. Rodríguez-Cruz and G. García-Alcocer 8. Molecular aspects of metallothioneins in dementiasGemma Comes, Anna Escrig, Yasmina Manso, Olaya Fernández-Gayol, Paula Sanchis, Amalia Molinero, Mercedes Giralt, Javier Carrasco and Juan Hidalgo 9. Implication of microRNAs in Alzheimer’s disease pathogenesisKatarzyn Marta Zoltowska, Katarzyna Laskowska-Kaszub, Siranjeevi Nagaraj and Urszula Wojda 10. Role of cellular oxidative stress in dementiaGiovanna Galliciotti, Antonella De Jaco, Diego Sepulveda-Falla, Emanuela D’Acunto and Elena Miranda 11. Toward an integrative understanding of the neuroinflammatory molecular milieu in Alzheimer disease neurodegenerationJuan M. Zolezzi, Paulina Villaseca and Nibaldo C. Inestrosa 12. Wnt signaling and dementiaCarolina Alquezár and Ángeles Martín-Requero 13. Linkage of atypical protein kinase C to Alzheimer diseaseRobert V. Farese and Mini P. Sajan 14. Linking histone deacetylases and phosphodiesterase 5 in novel treatments for Alzheimer’s diseaseAna Garcia-Osta and Mar Cuadrado-Tejedor 15. Nuclear factor erythroid 2-related factor 2 in Alzheimer’s diseaseKelsey E. Murphy and Joshua J. Park 16. Implications of alpha- and beta-secretase expression and function in Alzheimer’s diseaseSven Reinhardt and Kristina Endres 17. Methylation analysis of DNA in Alzheimer’s diseaseFabio Coppedè 18. The signalosome malfunctions in age-associated neuropathologiesRicardo Puertas-Avendaño, David Quinto-Alemany, Miriam González-Gómez and Raquel Marin 19. FAM3C in Alzheimer’s disease: a risk-related molecule and potential therapeutic targetMasaki Nishimura, Naoki Watanabe, Emi Hibino, Masaki Nakano, Yachiyo Mitsuishi, Lei Liu and Takuma Sugi 20. Amylin and amylin receptors in Alzheimer’s diseaseWen Fu and Jack H. Jhamandas 21. Mammalian target of rapamycin complexes: regulation and Alzheimer’s diseaseHenry Querfurth and Han-Kyu Lee 22. Mammalian target of rapamycin complexes: protein synthesis and autophagy, Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal dementiaHenry Querfurth and Han-Kyu Lee 23. Linking CD200 in brains and dementia: molecular aspects of neuroinflammationDouglas Gordon Walker Part II: Neurological, physiological and imaging 24. Hippocampal atrophy associated with dementia risk factors and dementiaHiroshi Yao, Yuko Araki, Fumio Yamashita, Makoto Sasaki and Manabu Hashimoto 25. Inflammation and insulin resistance in Alzheimer’s disease: partners in crimeYuval Nash and Dan Frenke 26. Brain susceptibility to hypoxia/hypoxemia and metabolic dysfunction in Alzheimer’s disease: insights from animal and in vitro modelsVito Antonio Baldassarro, Andrea Bighinati, Michele Sannia, Luciana Giardino and Laura Calzà 27. Neuropeptides and neurolipids: what they are and how they relate to Alzheimer’s diseaseIván Manuel, Laura Lombardero, Alberto Llorente-Ovejero and Rafael Rodríguez-Puertas 28. Neurotransmitter receptors in Alzheimer’s disease: from glutamatergic to cholinergic receptorsLaura Lombardero, Alberto Llorente-Ovejero, Iván Manuel and Rafael Rodríguez-Puertas 29. Aß42-a7-like nicotinic acetylcholine receptors and Alzheimer’s diseaseHoau-Yan Wang and Amber Khan 30. Synaptosomal bioenergetic defects in Alzheimer’s diseasePamela V. Martino Adami and Laura Morelli 31. Limitations of amyloid imaging in Alzheimer’s diseaseDavid Weidman 32. Linking gradient echo plural contrast imaging metrics of tissue microstructure with Alzheimer diseaseDmitriy A. Yablonskiy, Tammie L. Benzinger and John C. Morris 33. Hypertensive disorders during pregnancy and later dementia: is there a connection?Ellika Andolf 34. Unraveling the contributions of sleep dysfunction to Alzheimer’s diseaseElie Gottlieb, Natalie A. Grima, Mark Howard, Amy Brodtmann and Matthew P. Pase Part III: Behaviour and psychopathology 35. Overview of behaviors in dementiaDorothy M. Grillo and Rachel Anderson 36. Delirium superimposed on dementia: a clinical challenge from diagnosis to treatmentMorandi Alessandro, Pozzi Christian, Grossi Eleonora and Bellelli Giuseppe 37. Self-consciousness deficits in dementiaEva M. Arroyo-Anlló and Roger Gil 38. Attentional impairments to novel images in dementiaCelina S. Liu, Michael Rosen, Nathan Herrmann and Krista L. Lanctôt 39. Frontal lobe syndrome and dementiasPetronilla Battista, Chiara Griseta, Rosa Capozzo, Madia Lozupone, Rodolfo Sardone, Francesco Panza and Giancarlo Logroscino 40. The stigma of dementiaAlbert Aboseif and Benjamin K.P. Woo 41. Delusions in dementiasMadia Lozupone, Maddalena La Montagna, Antonello Bellomo, Petronilla Battista, Davide Seripa, Antonio Daniele, Antonio Greco, Onofrio Resta, Giancarlo Logroscino and Francesco Panza 42. Linking motor speech function and dementiaMatthew L. Poole and Adam P. Vogel 43. Spatial navigation and Alzheimer’s diseaseLaura E. Berkowitz, Ryan E. Harvey and Benjamin J. Clark 44. Violence and dementiaG. Cipriani, S. Danti, A. Nuti, L. Picchi and M. Di Fiorino 45. Factors contributing to protection and vulnerability in dementia caregiversFan Zhang, Sheung-Tak Cheng and Manuel Gonçalves-Pereira Part IV: Diet, nutrition and environment 46. Nutritional status of dementia and management using dietary taurine supplementationMi Ae Bae and Kyung Ja Chang 47. Selenium and Alzheimer’s diseaseAdriana Gisele Hertzog da Silva Leme and Barbara R. Cardoso 48. Linking adiponectin and obesity in dementiaMa1gorzata Bednarska-Makaruk 49. The impact of the gut microbiome in Alzheimer’s disease: cause or consequence?Malena dos Santos Guilherme and Kristina Endres 50. (-)-Epigallocatechin-3-gallate and Alzheimer’s diseaseLaura Xicota and Rafael de la Torre 51. Lead, cadmium and Alzheimer’s diseaseKelly M. Bakulski, Howard Hu and Sung Kyun Park Part V: Models and modelling in dementia 52. Alzheimer model 5xfad mice and applications to dementia: transgenic mouse models, a focus on neuroinflammation, microglia, and food-derived componentsTatsuhiro Ayabe and Yasuhisa Ano 53. Use of 192 IgG-saporin as a model of dementia and its applicationJ.W. Chang and Y.S. Park 54. Amyloid beta 1e42-induced animal model of dementia: a reviewJosiane Budni and Jade de Oliveira 55. Resources for the neuroscience of dementiaRajkumar Rajendram and Victor R. Preedy

Read more less

Book SynopsisTable of ContentsSection 1: Parkinson’s Disease: Introductory Chapters 1. A Short History of Parkinson’s Disease – from early 19th century and afterwards – an overview2. Living with Parkinson’s disease – from financial to emotional3. The epidemiology of Parkinson’s disease – an overview4. Clinical Features of Parkinson’s disease – an overview5. The natural history of Parkinson’s disease – an overview6. The prognosis of Parkinson’s disease – an overview7. The neurobiology of Parkinson’s disease – an overview8. The pathophysiology of Parkinson’s disease – an overview9. Molecular and cellular mechanisms associated with Parkinson’s disease – synuclein, amyloid protein, oligomers and beyond10. Quality of life in Parkinson’s disease11. Gait in untreated Parkinson’s disease12. Levodopa-induced dyskinesias13. Tremor in Parkinson’s disease14 The impact of Parkinson’s disease on the family and careers Section 2: Biomarkers and Diagnosis15. Tissue biopsies as biomarkers in Parkinson’s disease16. Spinal fluid for biomarker discovery in Parkinson’s disease17. Clinical biomarkers in prodromal Parkinson’s disease18. The diagnosis of Parkinson's disease19. Proteomics in Parkinson’s disease20. MicroRNAs as biomarkers in Parkinson’s diseases21. Phenotyping in Parkinson’s disease22. Diagnosis of speech disorders in Parkinson’s disease23. Identifying dementia in Parkinson’s disease 24. Diagnosis of sleep disturbances in Parkinson’s disease25. Diagnosis of Parkinson’s disease using magnetic resonance imaging26. Use of ultrasound as a diagnostic tool in Parkinson’s disease27. Use of single-photon emission computerized tomography (SPECT) as a diagnostic tool in Parkinson’s disease28. Use of positron emission tomography (PET) as a diagnostic tool in Parkinson’s disease Section 3: Pharmacological Treatments for Parkinson’s Disease29. Dopamine Agonists and Parkinson’s disease – an overview30. Management with Levodopa in Parkinson’s disease31. Management with ripinirole in Parkinson’s disease32. Management with pramipexole in Parkinson’s disease33. Management with rotigotine in Parkinson’s disease34. Management with apomorphine in Parkinson’s disease35. Management with MAO-B Inhibitors in Parkinson’s disease36. Management with COMT inhibitors in Parkinson’s disease37. Management with anticholinergics in Parkinson’s disease38. Management with amantadine in Parkinson’s disease Section 4: Novel and Non-Pharmacological Therapies For Parkinson’s Disease39. Treatment with chelator in Parkinson’s disease40. Treatment with deep brain stimulation in Parkinson’s disease41. Olive leaf extract usage as an antioxidant and applications to Parkinson’s disease42. Treatment with Vitamin D for Parkinson’s disease43. Chemogenetics and applications for Parkinson’s disease44. Flavonoids and naringin usage in Parkinson’s disease45. Stem cells and applications to Parkinson’s disease46. Treatment with cannabis for Parkinson’s disease47. Treating sleep problems in Parkinson’s disease48. Perioperative treatments of Parkinson’s disease49. Exercise and Parkinson’s disease50. Molecular aspects: CB2 receptors and neuroprotection in Parkinson’s disease

Read more less

Book SynopsisTable of ContentsPart I: Genetics, molecular and cellular biology 2. Alpha-synuclein gene and Parkinson’s diseaseAthina-Maria Simitsi, Chistos Koros and Leonidas Stefanis 3. The DJ-1 gene and protein: links with Parkinson’s diseaseVanessa J. Musco, Sarah J. Annesley and Paul R. Fisher 4. Regulation of tyrosine hydroxylase: relevance to Parkinson’s diseaseGelareh Alam and Jason R. Richardson 5. Linking glucocerebrosidase gene (GBA) variants and Parkinson’s diseasectoria Berge-Seidl and Mathias Toft 6. Astrocytes and microglia in Parkinson’s disease and animal modelsKatarzyna Kuter 7. The role of autophagy in Parkinson’s disease etiopathogenesisEmanuel Candeias, Jãao Duarte Magalhães, Daniel Santos, Helena Costa, Diana F. Silva, Ana Raquel Esteves and Sandra Morais Cardoso 8. The mitochondrial network in Parkinson’s diseaseAndreas Aufschnaiter, Verena Kohler and Sabrina Büttner 9. Signal transduction in Parkinson’s disease: modulation of neurotransmission, symptomatology, and therapyMattia Volta 10. Oxidative stress signaling and regulated cell death in Parkinson’s diseaseCarlos Velez-Pardo and Marlene Jimenez-Del-Rio 11. Subcellular-specific alpha-synuclein in Parkinson’s diseaseBenjamin Rosen, Ketan S. Patil, Guido W. Alves and Simon G. Møller 12. Melanocortin 1 receptor: Parkinson’s disease, melanoma risk, and neuroprotectionGemma Tell-Marti, Joan Anton Puig-Butillé and Susana Puig 13. Energy regulation and Parkinson’s diseaseLiting Hang and Kah-Leong Lim 14. Linking rotigotine, Parkinson’s disease, and brain-derived neurotrophic factorKazuhiro Sohya, Kazunori O’Hashi and Hiroshi Kunugi Part II: Neurology, physiology and imaging 15. The different syndromes in Parkinson’s disease: an overviewNikolaos Giagkou and Maria Stamelou 16. Neuromolecular imaging in Parkinson’s diseasePatricia A. Broderick and Leslie Wenning 17. Interlinking brain mapping and Parkinson’s disease: MRI analysis, nigrosome 1 and nigrosome 4Eung Yeop Kim, Young Hee Sung and Jongho Lee 18. Interconnecting Parkinson’s disease: the use of computed tomography and microelectrode recording in DBS surgeryRyan B. Kochanski and Sepehr Sani 19. Linking diffusion tensor imaging, microstructures and Parkinson’s diseaseYu Zhang, Norbert Schuff, I-Wei Wu and Duygu Tosun 20. Detecting parkinsonian degeneration in lateroventral tier of substantia nigra pars compacta with MRIJason Langley, Daniel E. Huddleston and Xiaoping P. Hu 21. Vagal motoneurons in Parkinson’s diseaseRuth E. Musgrove, Wei-Hua Chiu and Joshua A. Goldberg 22. Circadian clock disruption and neuroinflammation in Parkinson’s disease: a new perspective Elisabetta Lauretti and Domenico Praticò 23. Motor cortex stimulation in Parkinson’s diseaseAngelo Lavano, Giusy Guzzi, Attilio Della Torre and Domenico La Torre 24. Action programming disorders associated with Parkinson’s diseaseKenneth M. Heilman 25. The striatal medium spiny neurons: what they are and how they link with Parkinson’s diseaseFu-Ming Zhou 26. Disruptions of frontostriatal language functions in Parkinson’s diseaseAdolfo M. García, Yamile Bocanegra, Agustina Birba, Juan Rafael Orozco-Arroyave, Lucas Sedeño and Agustín Ibañez 27. Alpha-synuclein and neuroinflammation in Parkinson’s diseaseTatiana Varanita and Luigi Bubacco 28. Tau and its interactions with other proteins in neurodegenerative diseasesKatelyn H. Mroczek, Sarah J. Annesley and Paul R. Fisher 29. Interaction between brain angiotensin and dopaminergic systems and Parkinson’s diseaseJose Luis Labandeira-Garcia, Pablo Garrido-Gil, Maria A. Pedrosa, Carmen M. Labandeira and Ana I. Rodriguez-Perez 30. Restoring dopamine levels in Parkinson’s disease: neuronal pathways, agonists and antiinflammatory agentsÁgatha Oliveira-Giacomelli, C.M. Albino, Hellio Danny Nóbrega de Souza and Henning Ulrich Part III: Behaviour and psychopathology 31. Motivation and motivational aspects of Parkinson’s diseaseAbdeslam Chagraoui, Emilie Puginier and Philippe De Deurwaerdère 32. Linking anxiety, cognitive and sensory deficits to gait and balance deficits in Parkinson’s diseaseQuincy J. Almeida 33. Motor programs interlinking gait and bradykinesia in Parkinson’s diseaseTateo Warabi, Kiyoharu Inoue and Nobuo Yanagisawa 34. Olfactory disturbances in Parkinson’s diseaseLais S. Rodrigues, Juliane Fagotti, Adriano D.S. Targa, Ana Carolina D. Noseda, Jessica L. Ilkiw, Flavia W.C. Dorieux and Marcelo M.S. Lima 35. Interlinking dementia in Parkinson’s disease: nutritional correlates of body compositionArthur Oscar Schelp, Jéssica Emy Komuro, José Eduardo Corrente and Silvia Justina Papini 36. The role of the gastrointestinal system and gut microbiota in Parkinson’s diseaseJade Kenna and Ryan S. Anderton 37. Swallowing impairment in Parkinson’s diseaseMaira Rozenfeld Olchik, Marina Padovani and Annelise Ayres 38. The Mini Nutritional Assessment (MNA) and applications to Parkinson’s diseaseSvetlana Tomic 39. The efficacy of Bacopa monnieri extract in modulating Parkinson’s diseaseDr. Ravikumar Hosamani Part V: Models, modelling and resources 40. 6-hydroxydopamine-induced model of Parkinson’s diseaseKatarzyna Kaczynska and Kryspin Andrzejewski 41. Knockdown transgenic Drosophila and Parkinson’s diseaseMarlene Jimenez-Del-Rio and Carlos Velez-Pardo 42. Neuroprotection in animal models of Parkinson’s disease: exploring exercise, sound, and lightJohn Mitrofanis 43. Modeling with the A53T a-synuclein model of Parkinson’s diseaseThomas Musacchio, James B. Koprich and Chi Wang Ip 44. Linking the leucine-rich repeat kinase 2 gene, animal models, and Parkinson’s diseaseYulan Xiong and Jianzhong Yu 45. Neuroscience of Parkinson’s disease: recommended reading and resourcesRajkumar Rajendram, Vinood B. Patel and Victor R. Preedy

Read more less

Book Synopsis

Read more less

Book SynopsisTable of Contents1. Generalities, procedures and background information2. Rationale for names applied in the atlas3. Literature cited4. List of abbreviations and explanations5. Brain structures classified topographically by regions

Read more less

Book Synopsis

Read more less

Book SynopsisTable of Contents1. Methods 2. Photography and drawings 3. Stereotaxic reference system 4. Nomenclature and the construction of abbreviations 5. The basis of delineation of structures 6. Neuromeric subdivisions of the mouse brain

Read more less

Book SynopsisTable of ContentsI. Depression: Introductory Chapters 1. Clinical staging in depression 2. Neurodevelopmental theory of depression 3. Depression after pregnancy 4. Modeling maternal depression during pregnancy: Rodent models of Major Depressive Disorder with Peripartum Onset 5. Depression in mothers and mental health in children: Impact, risk factors and interventions 6. Depression in college students 7. Depression in disasters and traumatic events 8. Depression and associated Alzheimer s disease 9. Comorbidities of depression and Parkinson's disease 10. Understanding the relationship between depression and alcohol among students 11. Depression in obesity 12. Depression and heart rate variability 13. Neuroinflammation and depression 14. Interlinking antidepressants and the immune system II. Biomarkers and Diagnosis 15. Assessment scoring tools of depression 16. The Beck Depression Inventory: Uses and applications 17. The Hamilton Depression Rating scale: Uses and applications 18. The Patient Health Questionnaire (PHQ) 19. Screening for Antenatal Depression (AND) using self-report questionnaires: Conceptual issues and measurement limitations 20. Edinburgh Postnatal Depression Scale: Description and applicationsJacqueline 21. The Death Depression Scale: Description and applications 22. Depression Anxiety Stress Scales: Features and Applications 23. Arabic version of the two-question Quick Inventory of Depression: Description and applications (QID-2-Ar) 24. Depressive Symptoms and Biomarkers of Cardiovascular Disease 25. Thioredoxin as an antioxidant protein as a marker in depression 26. Methods of neuroimaging in depression: Applications to resting-state functional connectivity 27. Neural markers of depression in MRI III. Pharmacological Treatments for Depression 28. Angiotensin receptor 1 blockade as an antidepression strategy 29. Cannabinoid CB1 receptors and antidepressant effects 30. Agomelatine: profiles and applications to depression 31. Bumetanide and use in depressive states 32. Linking citalopram, serotonin reuptake inhibitors and depressed pregnant women 33. Citalopram and usage in sleep-deprivation-induced depression 34. Monoaminergic System and Antidepressants 35. Duloxetine usage in depression 36. Escitalopram and blonanserin as antidepressant agents linking in neurotrophic mechanisms 37. Ketamine and the role of (2R,6R)-Hydroxynorketamine in depression 38. Linking 5-Hydroxytryptamine, antidepressant actions of (R)-Ketamine and social stress model 39. Mirtazapine: Multi-target strategies for treating substance use disorder and depression IV. Counselling, Psychotherapy and Behavioural Treatments for Depression 40. Mindfulness-based cognitive therapy and depression 41. Online (web based) programs for depression 42. Clay art therapy on emotion regulation: Research, theoretical underpinnings, and treatment mechanisms 43. Solution-focused counselling: and use in postpartum depression 44. Transcranial direct current stimulation (tDCS) combined with cognitive emotional training (CET) as a novel treatment for depression V. Other Aspects of Treatment: Specific Groups, Monitoring and Novel Regimens 45. Putative effects of cannabidiol in depression and synaptic plasticity 46. Tanscutaneous vagus nerve stimulation in depression 47. Exercise for depression as a primary and comorbid with obesity disorder: A narrative 48. Acupressure and depression: a scientific narrative 49. Potential beneficial effects of Bifidobacterium breve A1 on cognitive impairment and psychiatric disorders 50. Coenzyme Q and use in depression 51. Gene expression in Major Depressive Disorder: peripheral and brain based studies 52. Electroconvulsive therapy for depression: effectiveness, cognitive side-effects and mechanisms of action 53. Depression and offspring DNA methylation 54. Other Aspects of Treatment: Specific Groups, Monitoring and Novel Regimens: Treating depression with Theta burst stimulation (TBS)

Read more less

Book SynopsisTrade Review"This handbook will be quite useful for students, interns, residents, and seasoned doctors of emergency medicine for initial guidance on diagnosis and treatment of various emergency conditions. Although it is completely lacking in references, I find the information to be accurate and reliable. The size of the book, in particular, makes it an attractive option." --© Doody’s Review Service, 2020, Benjamin A. Willenbring, MD, reviewer, expert opinionTable of ContentsI. Genetics, Molecular and Celluar Biology 1. Hereditary motor neuropathies 2. Dopamine transporter (DAT1) polymorphism and development 3. Genome wide association studies (GWAS) and neurodevelopment: Autism spectrum disorder 4. SNPs and cerebral palsy 5. Epigenetic regulation of cortical neurogenesis 6. Functions and dynamics of axonal mitochondria 7. Linking apoptosis and caspases in fetal neural tube defects 8. Brain oxidative stress in Down syndrome 9. Linking Adhesion GPCRs to Glial Cell Development and Function 10. Immunoglobulin cell adhesion molecule superfamily and neurodevelopment 11. Brain-derived neurotrophic factor (BDNF) and neurogenesis 12. slc7a5 and neural development 13. Linking SOX3, SRY and disorders of neurodevelopment 14. Neuronal Src-homology-2 (SH2)B adaptor protein-1 (Sh2b1) and brain growth 15. Effects of extrinsic factors and intracellular signalling and transcription factors regulating the development and cell fate of spinal cord ependymal cells 16. Signaling molecules controlling oligodendrocyte development and brain myelination II. Neurological and Imaging Features 17. Fetal brain structures: imaging oriented 18. Four-dimensional (4D) ultrasonography: Methods, uses and fetal neuroscience 19. Linking histology and neurological development of the fetal and infant brain 20. Development of Corticospinal tract axons: from embryonic stage to adulthood 21. Vascular endothelial growth factor (VEGF) and neurodevelopment 22. Brain-wide connectivity architecture: developmental aspects 23. Development and pathology of the germinal matrix 24. Development of the GABAergic network in the mouse spinal cord 25. Postnatal development, electrophysiology and sensory sural nerves 26. Neuroscience of the developing axonal strata in the human fetal brain 27. Neuroactive steroids and neurodevelopment 28. Voltage and ligand-gated ion channels appearance and function in neurodevelopment 29. Features of brain development over 13 years in preterms 30. The medial pulvinar in neurodevelopment 31. Cortical sulci in the human fetal brain and development 32. The prenatal development of the human cerebellum 33. Developing cerebello-cerebral connectivity in health and disease: a focus on epilepsy 34. Prenatal exposure to progestins: impact on neurodevelopment of the child III. Physiological Aspects 35. Brain lesion characteristics in relation to upper limb function in children with unilateral cerebral palsy 36. Maternal exercise and brain development 37. Pyramidal neurons: physiology, Pathophysiology and postnatal development 38. Working memory: physiology and neurodevelopment 39. EEG development in resting states 40. Availability and metabolism of thyroid hormones in the developing brain IV. Behavior and Psychopathological Aspects 41. Psychosocial issues and quality of life following childhood stroke 42. Neuropsychological function following childhood stroke 43. Youths with autism and working memory 44. Linking the mesial temporal lobe, 3D probabilistic maps and development 45. Cognitive aspects of Down Syndrome 46. Adolescent cannabis use and neurocognitive development 47. The Role of Social Anxiety in Autism and the Broader Autism Phenotype: Evidence from Childhood through Adulthood 48. Impact of touch on bonding and neurodevelopment 49. Neurobehaviour and catch up growth V. Diet and Nutrition 50. Caloric restriction and the developing brain 51. High-fat diet, tryptophan hydroxylase-2 mRNA expression and neurodevelopment 52. Bone mineral density and nutritional status in children with cerebral palsy 53. Epigallocatechin-3-gallate: Linking the neurogenesis, hippocampus and Down syndrome 54. Folic acid-to prevent spina bifida and anencephaly

Read more less

Book SynopsisTable of ContentsI. Genetics, Molecular and Cellular Biology1. Genetics of frontotemporal dementia2. Aging, brain-derived neurotrophic factor (BDNF) and its polymorphism3. Aging, demented patients, and polymorphisms in cytokine genes4. RNA fragments and brain aging5. Centrosome functions and remodeling during neuronal development and centrosome abnormalities in neuronal disorders, disease, and in aging6. Brain aging and microarray analysis7. Human nuclear tau and aging8. Lipoxidation: features, neurological tissues and aging9. Aging and brain amino acids10. How 3’,5’-cyclic nucleotide phosphodiesterases change in the brain with normal aging and dementia11. The prohibitin complex in aging and neurodegeneration12. Synaptic ATPase and energy metabolism in the nervous system: roles and changes in the aging process II. Neurological and Imaging Features13. Microstructural Imaging of the Human Brain with Normal and "Abnormal" Aging using Diffusion Magnetic Resonance Imaging14. Imaging the brain and its vascular in aging: Applications of optical coherence tomography angiography15. Potential involvement of perineuronal nets in brain aging: an anatomical point of view16. Grey-matter networks in aging17. Brain synapse-related proteins what they do and how they change in aging18. Macro- and chaperone-mediated autophagy in aging19. Neuronal L-type calcium channels in aging20. D-serine-regulated glutamatergic transmission and microglia: impact of aging21. Voltage-gated potassium channels and the aging brain22. Dendritic spine remodeling and aging23. High-density lipoprotein-cholesterol and neuroaging: memory, gyrification of the insular and frontal opercular cortex24. Astrocyte and microglial aging: morphology and modelling25. Neural scaffolding: features, profiles and the aging cerebellum26. BACE1 RNAi, memory and aging27. Aging, myelination and the optic nerve28. Linking proteostasis, brain aging, and ischemia29. Luteinizing hormone and the aging nervous system30. Insights into aging using transcranial magnetic stimulation31. Alpha rhythms: what they are and how they alter with aging32. Nicotine and its derivatives in healthy brain aging III. Physiological Aspects33. Environmental enrichment and physiological aging34. Treadmill exercise and neuroinflammation: links with aging35. Impact of aerobic exercise on brain structure in models of aging: hippocampus and beyond36. The physiology of fitness and the brain in aging37. Aging, Babble Noise and the processing of speech perception38. The blood-brain barrier in aging IV. Behavior And Psychopathological Aspects39. Linking aging, anticholinergic drug use, and cognitive impairment40. Cognitive Frailty: Definition, components and impact on disability, and mortality41. The physiology of the "Brain-muscle loop" in aging42. Disentangling the effects of aging and ovarian hormone loss on sleep: Implications for health and disease43. Role of DNA methylation in aging-related cognitive functioning'44. Depression in the elderly and psychobiotics V. Diet And Nutrition45. Aging, dietary patterns and cognition46. Geriatric nutritional risk index: Application, and limitations47. Diet, inflammatory biomarkers, and brain aging48. DASH diet and brain aging49. The ketogenic diet and healthy brain aging50. Autophagy and aging: diet, exercise, and the link with the target of rapamycin complex 1 (TORC)51. Dietary Flavonoids and Brain Health in Ageing: food for Thought52. Antioxidant effects of curcumin and neuroaging53. Lipoic acid and vitamin D3 and their use in preventing brain aging54. Aging and working memory: Impact of the leucine metabolite beta hydroxy-beta-methyl butyrate55. Hydration, the brain and aging

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisTable of ContentsI. Setting the scene: General aspects of anesthesia, analgesics and pain 1. The concept of multimorphic cancer pain: a new approach from diagnosis to treatment 2. Recent advances in the linkage of attachment and pain: a new review 3. The management of pain in older peopleFelicity 4. Anesthesia and body mass: epidural depth and beyond 5. Anesthetics and analgesic activities of herbal medicine: Review of the possible mechanism of action 6. Analgesia-first sedation and multimodal analgesia in the intensive care unit 7. The multidisciplinary Acute Pain Service: features and experiences 8. Monitoring anaesthesia: EEG and beyhond II. The syndromes of pain 9. Cluster headache and pain: features and treatments 10. Migraine and pain: features and treatments 11. Complex regional pain syndrome 12. Phantom limb pain. 13. Painful diabetic neuropathy: The roles of microglia 14. Maternal deprivation and nociceptiionIraci 15. Giving birth and pain 16. Abdominal Pain in Gastroparesi 17. Appendicitis and related abdominal pain 18. Ovarian hormones, site-specific nociception and hypertension 19. Linking the heart and pain: physiological and psychophysiological mechanisms 20. Chronic pain in military veterans 21. Nociception during surgery 22. Breast cancer and nociception 23. Postoperative pain after rhinoplasty and rhinologic surgery 24. Pain response, neonates and venipuncture 25. Carpal tunnel syndrome and pain 26. Pain and HIV 27. Pain mechanisms in computer and smartphone users III. Interlinking anesthesia, analgesics and pain 28. Patients' and health professionals' positions regarding the use of analgesics in cancer cases 29. Linking compression of myofascial trigger points and musculoskeletal pain 30. Multimodal analgesia and post-surgical pain 31. Pain, ultrasound-guided Pecs II block and general anesthesia 32. Pain control during prostate biopsy and evolution of local anesthesia techniqes 33. Pain reduction, in cosmetic injections: fillers and beyond 34. Anesthesia and combat-related extremity injury 35. Spinal anesthesia: applications to cesarean section and pain 36. Postoperative Pain Management: Truncal blocks in thoracic surgery 37. Postoperative Pain Management: Truncal blocks in general surgery 38. Linking analgesia, epidural oxycodone, pain and laparoscopy 39. Levobupivacaine features and linking in infiltrating analgesia IV. Assessments, screening and resources 40. The Pain Catastrophizing Scale: Features and Applications 41. The Pain Behaviour Scale (PaBS) 42. The analgesia nociception index: features and application 43. Back Pain Evaluation Questionnaire 44. The Back Pain Functional Scale: features and applications 45. Cognitive impairment, pain and analgesia 46. Biomarkers in endometriosis-associated pain 47. Biomarkers in bladder pain syndrome: a new narrative 48. Biomarkers of statin-induced musculoskeletal pain: Vitamin D and beyond 49. Performance-based and self-reported physical fitness as a powerful marker of musculoskeletal pain

Read more less

Book SynopsisTable of ContentsI. Drugs and agents used in anesthesia and analgesia 1. Anesthesia for malignant hyperthermia susceptible patients 2. Use of dextran in regional anesthesia 3. Intraperitoneal local anesthetic agents in the management of post-operative pain 4. Automatic control of anesthesia via different vital signs 5. Non-opioid based analgesia in otolaryngology II. Mechanisms of action of drugs 6. Buprenorphine: mechanisms and applications 7. Caffeine usage in pain management 8. Chloroprocaine: features and applications 9. Clonidine: features and applications 10. An excursion into secondary pharmacology of fentanyls with potential implications for drug design: s1 receptor 11. Isoflurane: mechanisms and applications 12. The lidocaine patch: features and applications: post-thoracotomy pain and beyond 13. Memantine: features and application to chronic pain control 14. Midazolam: Perioperative administration 15. Intravenous paracetamol: features and applications 16. Prilocaine: mechanisms and applications 17. Sevoflurane: features and use in topical application for wound care 18. Tramadol as an analgesic III. Adverse effects, reactions and outcomes 19. Long-term effects of anaesthesia on the brain: an update on neurotoxicity 20. Neuraxial labour analgesia and breast feeding 21. Mechanistic Overview of How Opioid Analgesics Promote Constipation 22. Cognitive-behavioral therapy for opioid use disorder and chronic pain 23. Preoperative opioid and benzodiazepines: impact on adverse outcomes 24. Anesthetics, Malignant hyperthermia syndrome and Kv7 channels 25. Problems with epidural catheter 26. Headache after neuroaxial blocks: a focus on combined-epidural anesthesia 27. Liposomal bupivacaine, pain relief and adverse events 28. Adverse events associate with analgesics: a focus on paracetamol use IV. Novel and non-pharmacological aspects and treatments 29. Acronychia pedunculata leaves and usage in pain 30. Adansonia digitata and use in neuropathic pain: prostaglandins and beyond 31. Andrographis paniculata standardized extract (ParActin) and pain 32. Capsaicin: features usage in diabetic neuropathic pain 33. Cola nitida and Pain reliefLawrence 34. Analgesic effects of Ephedra Herb extract and ephedrine alkaloids-free Ephedra Herb extract (EFE) 35. Euphorbia bicolor (Euphorbiaceae) Latex Phytochemicals and applications to analgesia 36. Pain relieving activity of muntingia calabura l.: elucidation of possible mechanisms of action and identification of responsible phytoconstituents 37. Resolving neuroinflammation and pain with Maresin 1, a specialized pro-resolving lipid mediator 38. Therapeutic role of naringenin to alleviate inflammatory pain 39. Analgesic properties of Solanum paniculatum and S.torvum extracts 40. Dietary constituents contribute to local anesthetic agent: neurophysiologicals mechanism of nociceptive pain 41. Pain response following prenatal stress and its modulation by antioxidants 42. Physical activity and fitness in the prevention of musculoskeletal pain in youth 43. Linking aerobic exercise and childhood pain alleviation: a narrative 44. Physical activity and exercise in the management of musculoskeletal pain: a focus on fibromyalgia 45. Spinal cord stimulation and limb pain 46. Effectiveness of neural mobilization on pain and disability in individuals with musculoskeletal disorders 47. Virtual reality and applications to treating neck pain 48. Virtual reality-induced analgesia and dental pain 49. Vibrotactile devices, DentalVibe and local anesthesiaElitsa 50. Cooled radiofrequency ablation (CRFA) and osteoarthritis treatment for pain 51. Non-pharmacologic analgesic therapies: a focus on photobiomodulation, acustimulation and cryoanalgesia (ice) therapy 52. New coping strategies and self-education for chronic pain management: e-health 53. Postoperative Pain Management Truncal blocks in obstetric and gynecologic surgery

Read more less

Book SynopsisTable of ContentsSection 1 – Methods, Biomarkers, and Diagnosis1. Imaging Zika virus infection2. Use of CRISPR: applications to flaviviruses3. Methods of investigating neurotoxicity of larvicides: applications of systems biology4. Methods for the detection of Zika virus infectivity Section 2 – Vector Control, Vaccines, Pharmacology 5. Vector control and Zika virus: a focus on mosquitoes6. Vector control: a focus on rural household containers: applications to Zika virus7. Zika virus Vaccines: an overview8. Novel treatment with 2,8-bis(trifluoromethyl)quinoline analogs in Zika infection in vitro9. Zika virus use of human neutralizing antibody in microcephaly prevention: a modelling system10. Policies on Zika virus Control Section 3 – Novel and Non-Pharmacologic Therapies11. Role of the pediatric neurologist in treating Zika virus syndrome12. 25-Hydroxycholesterol usage in Zika Virus Infection13. Screening and inhibition of the flavivirus NS2B-NS3 protease: application to zika virus14. Gene silencing and applications to zika virus15. Screening phytochemicals that react against Zika virus Section 4 – Models and Modelling16. Guinea pig model of Zika virus: features and applications17. Rat model of Zika virus: features and applications18. Mouse model of Zika virus: features and applications19. Modelling Zika virus in the USA20. Modelling Zika virus infection in laboratory animals: impact on neurological systems Section 5 – Neuroscience of Guillain-Barré Syndrome21. Severe Guillain-Barré Syndrome22. Plasmablasts, plasma and neurotoxic antibodies in Guillain-Barré syndrome23. Oxidative stress in Guillain-Barré Syndrome and linkage with neurology24. Neuromuscular effects and rehabilitation in Guillain-Barré syndrome25. Post-infectious demyelinating diseases: Guillain-Barré syndrome and beyond Section 6 – Neuroscience of Microcephaly26. Microcephaly and developmental delays27. Congenital microcephaly: features and risk factors28. Microcephaly in fetal alcohol syndrome29. Microcephaly in genetic disorders: the case of MFSD2A and hypomyelination30. Folate metabolism, 5,10-methenyltetrahydrofolate synthetase and microcephaly Section 7 – International Aspects31. Zika Virus in Honduras32. Zika Virus in Uganda33. Zika Virus in Jamaica34. Zika virus in Mozambique35. Zika virus in Brazil Section 8 – Case Reports36. Case reports: Zika and Chikungunya virus infection37. Case reports: Zika virus neuroretinitis38. Case reports: Zika virus infection in Singapore39. Case reports: Coinfection with Zika virus and dengue-2 viruses40. Case report: Guillain-Barré and Zika virus infection

Read more less

Book SynopsisTable of ContentsSection 1 – Zika Virus: Introductory Chapters1. Flaviviruses and where the Zika virus fits in: An overview2. The Zika virus: A brief overview3. The public health perspective of Zika virus-infection4. Zika virus as a potential pandemic5. Zika virus, symptomatic and asymptomatic travellers6. Microcephaly: features, and impact7. Microcephaly and Zika virus: a short and focused overview8. Guillain-Barré Syndrome and Zika viral infections9. Non neurological effects of Zika virus infection10. Guillain-Barré syndrome11. Quality of life in mothers of children with microcephaly Section 2 – Impact on Neurological Systems 12. Zika virus, immunobiology and autoimmune neurological syndromes in Calcutta13. Impact on Zika virus on paralysis and neuro-inflammation: Jamacian aspects14. Linking Guillain-Barré and Zika virus infection15. Puerto Rico aspects: Linking Zika virus infection and Guillain-Barré syndrome16. Zika virus infection and cytokines17. Linking microRNAs, Wnt signaling pathway and Zika virus18. Neuronal conduction in Guillain-Barre syndrome19. Features of Guillain-Barré syndrome with or without Zika virus20. Auditory brainstem in Zika virus infection21. Neurology without microcephaly in Zika virus22. Neurologic manifestations, Zika virus and the adult brain23. Infantile Spasms in offspring due to maternal Zika virus24. Encephalomyelitis and Zika virus infection25. Cerebrospinal fluid in microcephaly of Zika virus26. The developing neocortex in Zika virus infection27. Glial cell development and Zika virus28. Myelination, microcephaly and Zika virus29. Neuronal apoptosis in congenital Zika virus infection30. Zika virus and fetal imaging31. PET Imaging and neuroinflammation in Zika Virus-Infection32. Neonatal brain magnetic resonance and normocephalics in Zika virus infection33. Zika virus and adult human brain structure Section 3 – Features of the Virus and Transmission34. Zika virus and codon usage bias35. Comparing Zika virus transmission with other viruses: Chikungunya virus36. Vectors of Zika virus transmission: Asian Tiger Mosquito (Aedes albopictus37. Linking Zika virus, dengue virus and modes of transmission38. Breast milk and mother-to-child transmission39. Zika virus due to sexual transmission

Read more less

Book SynopsisTable of ContentsI. Molecular and cellular aspects 1. Gene expression, KCNQ/Kv7 channels and neuropathic pain 2. The NTRK1 gene and congenital insensitivity to pain 3. Prdm12, a key transcriptional regulator of the nociceptive lineage 4. Linking the genetics of fibromyalgia and painFernando 5. Fentanyl: Polymorphisms, and adverse events 6. Propofol anesthesia and molecular changes in the brain 7. Protein Kinase G is a Molecular Switch for Pain 8. Adrenergic agonists and the mu opioid receptor 9. Inflammatory and neuropathic pain impact on the opioid function in the mesocorticolimbic systemL 10. Clinacanthus nutans, analgesia and the l-arginine/nitric oxide-mediated/cyclic-guanosine monophosphate-independent pathway 11. alpha2/3-selective GABAA receptor PAMs as pain medications 12. alpha5GABAA receptors and their role in pain perception 13. ATP sensitive potassium channels in pain and analgesia 14. Astrocyte-neuron lactate shuttle and pain 15. Nociception and sweet solutions: applications to inflammatory pain 16. Interlinking Interleukin-33 (IL-33), neuroinflammation and neuropathic pain 17. Neurons of the parabrachial nucleus, nociceptive input and pain pathways 18. Anterior cingulate cortex, pain perception and pathological neuronal plasticity during chronic pain 19. Sleep deprivation headaches and Fos immunohistochemistry 20. Antinociceptive glucagon-like peptides 21. Pain transmission and peripheral group III metabotropic glutamate receptors (mGluRs) 22. TRPM -8 receptor and menthol in pain management II. Physiology, imaging and physical recordings 23. Anesthetic and proconvulsant effects of ketamine on EEG 24. Electroencephalography and anesthetic doses of ketamine 25. Linking heart function and analgesia 26. Computed Tomography-guided procedures for epidural injections 27. Chronic pain: Linking deep brain stimulation and sensory functional MRI 28. Neurocognition and placebo analgesia: linking in functional magnetic resonance imaging 29. Linking the cortex, functional spectroscopy and pain: features and applications 30. Muscle origins of myofascial pain syndrome III. Psychology and Behaviour 31. Behavioral markers of pain 32. Adverse life events, sensitization of spinal nociception, and chronic pain risk 33. Cognitive-affective modulation of pain: The Placebo and nocebo phenomena and their impact on pain treatment 34. Nociception-related behavioral phenotypes in adult zebrafish 35. Pain, implantable pain devices and psychosocial aspects as a narrative 36. Influence of psychological factors in myofascial pain IV. Resources 37. Resources

Read more less

Book SynopsisTable of ContentsSection I. Introduction 1. Introduction: On brain and crime Section II. Structure and Function 2. Genetics and epigenetics of human aggression 3. Network localization of antisocial behavior in neurological patients: Evidence and implications 4. Prison and the brain 5. Forensically relevant challenging behaviours and the genetics domain 6. Social-affective functioning and learning in psychopathy 7. Amygdala connectivity and ggression 8. The "(a)moral brain": When things go wrong Section III. Brain dysfunction 9. Illicit drug use and violence 10. Child maltreatment and victimization 11. Sexual offenses and the brain 12. The risk of criminal behavior in the elderly and patients with neurodegenerative disease 13. Fetal alcohol spectrum disorders and the risk of crime Section IV. Assessment and Treatment 14. Cognition, criminal conduct, and virtual reality: Understanding and reducing offending using simulated environments 15. Added value of neurotechnology for forensic psychiatric and psychological assessment Section V. Ethics and Law 16. Neurolaw: Challenges and limits 17. Why neuroscience changes some things but not everything for the law 18. Neurotechnology to reduce recidivism: Ethical and legal challenges

Read more less

Book SynopsisTable of ContentsIntroduction Source of Tissue Histology Photography/Imaging Diagrams and Labeled Photographs In Vivo MRI Stereotaxic Grid Nomenclature and Abbreviations Gene Expression Reveals the Segmentation of the Brainstem The Construction of Abbreviations in the Paxinos/Watson Nomenclature The Basis of the Delineation of Structures Efferent and Afferent nuclei of the Cranial Nerves Reticular and Tegmental Nuclei of Brainstem Monoamine Nuclei of the Brainstem Precerebellar Nuclei and Red Nucleus Nuclei Related to the Visual System

Read more less

Book SynopsisTrade Review"This book is a valuable effort for those working in the field of the human hypothalamus. The images are of uniform quality and printed off bright white quality paper. There is no comparative textbook as detailed on this area." --© Doody’s Review Service, 2021, Brian R. MacPherson, PhD, reviewer, expert opinionTable of ContentsPart 1. General anatomic description with plastinated brain specimens and schematical drawings of pathways and nuclei Part 2. 130 sections of hypothalamus with corresponding contour maps

Read more less

Book SynopsisTable of ContentsSECTION I. Operative Approaches 1. Olfactory groove and planum meningiomas 2. Tuberculum sellae meningiomas 3. Clinoidal meningiomas 4. Sphenoid wing meningiomas 5. Hyperostosing sphenoid wing meningiomas 6. Middle fossa meningiomas 7. Cavernous sinus meningioma 8. Convexity meningioma resection in the modern neurosurgical era 9. Parasagittal meningiomas 10. Falcine meningiomas 11. Falcotentorial meningiomas 12. Role of the neurotologist in posterior fossa meningioma surgery 13. Petroclival meningiomas and the petrosal approach 14. Anatomy of petrous face 15. Petrous face meningiomas 16. Foramen magnum meningiomas 17. Intraventricular meningiomas SECTION II. Special Considerations 18. Seizures in meningioma 19. Image-guided surgery for meningioma 20. Carotid artery occlusion and revascularization in the management of meningioma 21. Endoscopic technology and repair techniques 22. Nasal septal flap repair of the skull base 23. Atypical meningiomas 24. Malignant meningiomas 25. Spinal meningiomas SECTION III. Adjuvant Treatments 26. External beam radiation therapy for meningioma 27. Radiation therapy of meningioma 28. Medical management of meningiomas 29. Brachytherapy for meningiomas SECTION IV. Quality of Life Issues 30. Quality of life outcomes in meningioma surgery 31. Rehabilitation from meningioma 32. End of life care for patients with meningioma

Read more less

Book SynopsisTable of ContentsSection 1. Setting the Scene: The Spectrum of Traumatic Brain Injuries 1. Slips, falls and traumatic brain injury 2. Road traffic accidents and traumatic brain injury 3. Sports, risks and brain injury 4. Traumatic brain injury and gunshot wounds 5. Blast waves and brain injury 6. Military veterans with brain injury 7. Gender and traumatic brain injury 8. Pediatric abusive head trauma and brain injury 9. Perinatal traumatic brain injury 10. Non traumatic brain injury:A focus on irradiation 11. The caregivers of traumatic brain injured subjects Section 2. Cellular and Molecular Aspects of Traumatic Brain Injury 12. Subcellular organelles in traumatic brain injury: a focus on mitochondrial changes 13. Diffuse axonal injury and traumatic brain injury 14. Electrolytes and traumatic brain injury: a focus on sodium 15. Neurotransmitters and traumatic brain injury: a narrative 16. The role of prokineticin 2 in traumatic brain injury 17. Traumatic brain injury, and Leucine-rich repeat kinase 2 (LRRK2) 18. C-C motif chemokine receptor 5 and traumatic brain injury 19. Neuronal cell death pathways in traumatic brain injury Section 3. Physiological and Metabolic Effects 20. Cerebral blood flow and traumatic brain injury 21. Traumatic brain injury and raised intracranial pressure 22. Oedema in traumatic brain injury 23. Traumatic brain injury and the vasculature: a focus on cerebral arteriole inflation 24. Elevated intracranial pressure in traumatic brain injury 25. Seizures in traumatic brain injury 26. Traumatic brain injury and impact on endocrinology: a focus on pituitary function 27. Sensory features and loss after traumatic brain injury: a focus on olfactory senses 28. Traumatic brain injury and impact on metabolism: a focus on hyperglycemia 29. Traumatic brain injury and impact on non-neurological body systems: a focus on bone Section 4. Behavioural and Psychological Effects 30. Traumatic brain injury and mental health: military perspectives 31. A focus on depression in traumatic brain injury 32. Personality disturbances in brain trauma 33. Sleep and traumatic brain injury 34. Cognitive recovery and traumatic brain injury 35. Brain injury and resulting hallucinations 36. Use of smartphone application by subjects with traumatic brain injury

Read more less

Book SynopsisThis thought-provoking tour through the science of magic will make you question what you know about your brain and your reality. A psychologist and magician shows how the scientific study of magic reveals intriguing—and often unsettling—insights into the mysteries of the human mind. What do we see when we watch a magician pull a rabbit out of a hat or read a person’s mind? We are captivated by an illusion; we applaud the fact that we have been fooled. Why do we enjoy experiencing what seems clearly impossible, or at least beyond our powers of explanation? In Experiencing the Impossible, Gustav Kuhn examines the psychological processes that underpin our experience of magic.   Kuhn, a psychologist and a magician, reveals the intriguing—and often unsettling—insights into the human mind that the scientific study of magic provides. Magic, Kuhn explains, creates a cognitive conflict between what we bel

Read more less

Book Synopsis

Read more less

Book SynopsisTable of ContentsPreface 1. Neurological Disorders in the Context of the Global Burden of Disease Rajkumar Rajendram I. Alzheimer’s Disease and Dementias 2. Lifestyle Modifications and Nutrition in Alzheimer's Disease Jasvinder Singh Bhatti 3. The Gut Microbiota and Alzheimer's Disease Monica Morales, Daniel Cuervo-Zanatta, Julieta Hernandez-Acosta, Marina Hernandez-Chacon, Vincente Sánchez-Valle and Claudia Perez-Cruz 4. The Mediterranean Diet: Unsaturated fatty acids and prevention of Alzheimer's disease José Antonio Estrada and Irazú Contreras 5. Malnutrition and early-stage Alzheimer's disease Sameer Chaudhary, Sapana Chaudhary, Sakshi Rawat and Jayashri Prasanan II. Amyotrophic lateral sclerosis 6. Hydration in amyotrophic lateral sclerosis Adriana Leico Oda 7. Diet disease severity and energy expenditure in ALS S. T. Ngo 8. Nutrition, percutaneous endoscopic gastrostomy and ALS Michele Barone and Isabella Laura Simone 9. Fatty acid profiling in amyotrophic lateral sclerosis Rajna Minic, Aleksandra Arsic and Zorica Stevic III. Brain Injury 10. High-fat diet in traumatic brain injury: neuroinflammation and beyond Nour-Mounira Z. Bakkar, Stanley Ibeh, Ibrahim AlZaim, Ahmed F. El-Yazbi and Firas H. Kobeissy 11. Brain injury, anthropometry and nutrition Sivashanmugam Dhandapani and Manju Dhandapani 12. Calorie and Protein Intakes in Traumatic Brain Injury Patients Aryati Ahmad 13. Lipids, docosahexaenoic acid (DHA) and traumatic brain injury Batoul Darwish, Carla El-Mallah, Firas H. Kobeissy, Wassim Abou-Kheir and Farah Chamaa 14. Brain trauma, ketogenic diets, ketogenesis and via an enteral nutrition Hayden White IV. Cerebral Palsy 15. Nutrition and cerebral palsy E. Keles Alp 16. Metabolic syndrome in adult cerebral palsy: implications for diet Patricia Cristine Heyn, Elizabeth A. Terhune, Alex Tagawa and James Carollo 17. Gut microbiota composition and cerebral palsy Yinhu Li and Shuai Cheng Li 18. Swallowing problems: Major components of nutritional deficits in adults with cerebral palsy You Gyoung Yi V. Dietary Neurotoxins 19. Dietary neurotoxins: an overview Yogesh A. Kulkarni Sr. 20. Alcohol consumption induces oxidative damage, neuronal injury, and synaptic impairment. Consequences for our brain health R. A. Quintanilla and Margrethe Olesen 21. Dietary effects of lead as a neurotoxin Ericka Cabañas, George Cruz, Michelle Vasquez, Jewel Joseph, Evan Clarke, Asma Iqbal, Bright Emenike, Wei Zhu, Patrick Cadet, Narmin Mekawy, Abdeslem El Idrissi, Morri Markowitz and Lorenz Simon Neuwirth 22. Environmental toxicants (OPs and heavy metals) in the diet: What are their repercussions on the behavioral/neurological system? Caridad López-Granero, Michael Aschner and Fernando Sánchez-Santed VI. Epilepsy 23. Hypercholesterolemic diet and status epilepticus Romildo A. Nogueira 24. Low glycemic index therapy (LGIT): what it is and how it compares to other diets epilepsy Sheffali Gulati 25. Ketogenic diet in pediatric Epilepsies Mario Mastrangelo VII. Headaches and Migraines 26. Fruit, vegetables and pediatric migraine headache Mansoureh Togha 27. Dietary trigger factors of migraine Mei-Ling Sharon Tai VIII. Multiple Sclerosis 28. Diet and nutrition in multiple sclerosis management Rabie Khattab and Yasmin Algindan 29. Dietary fish intake and multiple sclerosis: a new narrative Sama Bitarafan, Mohammad Harirchian, Payam Farahbakhsh and Danesh Soltani 30. Linking diet, gut microbiota and multiple sclerosis Sama Bitarafan, Mohammad Harirchian, Payam Farahbakhsh and Danesh Soltani 31. Restoration of myelination in the central nervous system via specific dietary bioactive lipids: An opportunity to halt disease progression in multiple sclerosis Liam Graneri, John CL Mamo, Ryusuke Takechi and Virginie Lam IX. Neuroinflammation 32. Effect of diet and nutrition in neuroinflammation: an oveview Yogesh A. Kulkarni Sr. 33. High fat diet induced cellular neuroinflammation: Alteration of brain function and associated aliments Aman B. Upaganlawar 34. High-fructose diets and neuroinflammation Gretchen N. Neigh X. Parkinson’s Disease 35. The Mediterranean diet and Parkinson's disease Mohannad Almikhlafi, Badrah Alghamdi and Ghulam Md Ashraf 36. Role of Dietary Antioxidants and Redox Status in Parkinson's Disease Reza Amani and Sanaz Mehrabani 37. Beverages, caffeine and Parkinson’s disease Karl Bjørnar Alstadhaug 38. The association of diet and its components in changes of gut microbiota and improvement of Parkinson’s disease Abdolreza Norouzy XI. Peripheral Neuropathy 39. Alcohol-related autonomic dysfunction and peripheral neuropathy Panagiotis Zis 40. Dietary saturated and monounsaturated fatty acids and peripheral neuropathy Masha Savelieff, Bhumsoo Kim, Amy Rumora and Eva L. Feldman 41. Caloric restriction and peripheral neuropathy Sara Marinelli XII. Prenatal Effects and Neurodevelopment 42. The interplay between stress and nutrition during pregnancy: Influence on fetal brain development Aman B. Upaganlawar 43. Maternal and neonatal polyunsaturated fatty acid intake and risk of neurodevelopmental impairment in premature infants Thomas Ragnar Wood 44. Early nutrition, growth and neurodevelopment in the preterm infant Frank H. Bloomfield and Barbara E. Cormack 45. Breast milk and cognitive performance in children Kamini Dhanesh Dangat and Sadhana R. Joshi 46. Ketogenic diets and ketone supplementation on the nervous system during development. Applications to autism spectrum disorders and schizophrenia Calogero Longhitano XIII. Stroke 47. Fluids, energy intake and stroke Alex Buoite Stella, Marina Gaio and Paolo Manganotti 48. Cachexia after stroke N. Scherbakov 49. Linking stroke and dietary pattern: An Indian Perspective Sandhya Manorenj 50. Dietary lipids, effect of docosahexaenoic acid on stroke-related neuronal damage Kazuo Yamagata 51. Diet quality and stroke Mitchell Wilson and Jennifer Dearborn-Tomazos 52. Resources Rajkumar Rajendram

Read more less

Book SynopsisTable of ContentsPreface 1. Vitamins and Minerals and in the context of reference values and requirements Rajkumar Rajendram I. Alzheimer’s Disease and Dementias 2. Alpha-tocopherol for Alzheimer’s disease Amal Kaddoumi 3. Cognitive impairment and micronutrients: Vitamin B12, folate, and homocysteine and implications for dementia Gianluca Rizzo and Angela Marino 4. Magnesium and Alzheimer's disease Dènahin Hinnoutondji Toffa and Jimmy Li 5. Copper, Oxidative Stress, Alzheimer's disease and Dementia Rosanna Squitti, Mauro Rongioletti and Gianfranco Liguri 6. Chromium and Alzheimer's disease Sangeeta Pilkhwal Sah and Ansab Akhtar II. Amyotrophic Lateral Sclerosis 7. Riboflavin and lower motor neuron diseases Y. Nadjar III. Brain Injury 8. Vitamin C (L-Ascorbic Acid) in Brain Injury Stefan W. Leichtle, Sulaiman Al Mohaish, Melissa Sandler, Vishal Yajnik, Dennis Rivet, Markos Kashiouris, Alpha Fowler and Gretchen M. Brophy 9. Antioxidant vitamins in brain injury with or without antibiotics Anoop Kumar I 10. Vitamin D and traumatic brain Injury Ajay Choudhary 11. Zinc and traumatic brain injury: implications for dietary modulation Paul A. Adlard IV. Cerebral Palsy 12. Cerebral palsy: Evaluating vitamin D levels M. A. Bellomo-Branda V. Dietary Neurotoxins 13. Linking copper and neurotoxic activities Gesivaldo Santos VI. Epilepsy 14. Epilepsy-derived neurodegeneration and vitamin E Francesco Galli 15. Selenium use in epilepsy Haitham S. Mohammed 16. Reduced Vitamin C and minerals in epilepsy Mohammad Safiqul Islam 17. Thiamine, transporters and epilepsy Sunita Bijarnia-Mahay, Arushi Gahlot Saini and Harjit Singh Mahay VII. Headaches and Migraines 18. Riboflavin usage in pediatric migraine Gaku Yamanaka 19. Vitamin B12, folate and migraine Ioannis Liampas, Vasileios Siokas, Christos Bakirtzis and Efthimios Dardiotis 20. Vitamin D and migraine Parisa Gazerani VIII. Multiple Sclerosis 21. Iron, zinc and multiple sclerosis patients Jamilah Borjac and Alaa Matar 22. Vitamin D3 supplementation and multiple sclerosis Joost Smolders and Jan Damoiseaux IX. Neuroinflammation 23. Magnesium reducing neuroinflammation Renu Agarwal and Igor Iezhitsa 24. Vitamin B12 as a neuroprotectant in neuroinflammation Roney S. Coimbra, Larissa Cassiano and Marina Oliveira 25. Vitamin D (VD3) effects on neuroinflammation and neurodegenerative disorders: focus on Alzheimer’s and Parkinson’s diseases Glauce.Socorro de Barros Viana 26. Vitamin c and neuroinflammation Amanda Marino, David Consoli and Fiona E. Harrison 27. Vitamin A and all trans retinoic acid ( ATRA) on neuroinflammatory changes in the brain Saritha Nair, S. Priyanka and Indira M 28. Fluoride Excess and Neuroinflammation Varun Kumar Sharma, Charu Tyagi, Dudha Namrata, Yugandhar Reddy and Lomas Kumar Tomar X. Parkinson’s Disease 29. Vitamin D and Parkinson's disease Valeria Gonçalves, Fúlvio Scorza, A.C. G. Almeida and Carla A. Scorza 30. Tocotrienols and Parkinson's disease: modelling in vivo and vitro Tatsuya Matsura 31. B vitamins, pyridoxal phosphate and Parkinsonism Adejoke Y. Onaolapo and Olakunle James Onaolapo 32. Antioxidant vitamins in Parkinson’s disease: Vitamins A, C and E Woon-Puay Koh and Ariel Fangting Ying 33. Calcium- and Parkinson’s disease Payam Saadat and Kiarash Saleki 34. Micronutrient levels in Parkinson's Disease H. Afridi Sr. 35. Genes and dietary metals in Parkinson disease Shiek SS.J Ahmed, Jency Roshni, Mahema S. and Janakiraman V XI. Peripheral Neuropathy 36. Vitamin D levels and diabetic peripheral neuropathy Rizaldy Pinzon, Angela Angela, Vanessa Veronica, Febrina Eva Susanto and Andryawan Pradana 37. B Vitamins in the nervous system: a focus on peripheral neuropathy Ana María Páez-Hurtado, Maria Camila Cortes-Albornoz, Diego Alejandro Rodríguez-Gomez, Carlos Calderón-Ospina and Mauricio O. Nava-Mesa XII. Prenatal Effects and Neurodevelopment 38. B-vitamins, deficiencies and maternal over supplementation on neurodevelopment: an updated narrative McCoy Clementson, Jesse Jauhal and Nafisa M. Jadavji 39. Trace elements in neurodevelopment: an updated narrative Anatoly Skalny, Lyubov Chernova and Anastasia Skalnaya 40. Gestational Folic Acid in Neuronal Development of the Hypothalamus G. H. Anderson XIII. Stroke 41. Vitamin B12, hyperhomocysteinaemia and stroke J. David Spence 42. Dietary sodium and stroke: A new narrative Ahmad Jayedi and Sakineh Shab-bidar 43. Dietary calcium and stroke Ka Kahe 44. Resources Rajkumar Rajendram

Read more less